New Patent Rights Clause Samples

New Patent Rights. If any patentable inventions or discoveries that are related to the inventions claimed in the Licensed Patents are disclosed to The University of Chicago Office of Technology and Intellectual Property by Professor Dmitri Talapin ( “New Disclosure(s)”), provided that the New Disclosure is not subject to any pre-existing (as of the date of the disclosure) conflicting third party agreements, then Chicago shall notify Company in writing of the New Disclosure and give Company a two (2) month exclusive opportunity to evaluate the New Disclosure (the “Evaluation Period”). During the Evaluation Period, Chicago and Company will discuss the New Disclosures in person or by teleconference. The Evaluation Period described in this Section 3.7 may be extended by mutual written agreement of the Parties.

New Patent Rights. Subject to the terms and conditions of this Agreement, the Company hereby grants, and shall cause each Company Licensee to grant, to the applicable Pfizer Licensor a royalty-free, fully paid-up, sublicensable, exclusive license in, to and under the New Patent Rights that are owned by such Company Licensee for all uses in the Pfizer Field in the Territory.

New Patent Rights. LICENSOR grants to LICENSEE a non-sub-licensable, fully-paid, royalty-free, perpetual license to any intellectual property related to the New Patents - that does not rely on the underlying Technology which must be licensed separately from New Patents.

New Patent Rights. “New Patent Rights” means (i) all patents and patent applications conceived and reduced to practice by Manufacturer or jointly by Buyer and Manufacturer (or their respective agents) concerning any invention conceived by Manufacturer or jointly by Buyer and Manufacturer during the term of this Agreement that relates to any manufacturing design and manufacturing process conceived in connection with Manufacturer’s performance of the obligations under this Agreement, and (ii) any divisions, continuations, continuations-in-part, reissues, reexaminations, extensions or other governmental actions which extend any of the subject matter of the patent applications or patents in (i) above, and any substitutions, confirmations, registrations or revalidations of any of the foregoing.

New Patent Rights. Subject to Section 7.1(b), Himalaya shall own all right, title and interest in and to New Patent Rights in the Territory and BioAtla shall own all right, title and interest in and to New Patent Rights in the ROW for inventions developed by and on behalf of such party. To the extent Himalaya, its Affiliates, Licensees, or Third Party Service Providers and their respective personnel or agents or Affiliates are deemed to have an inventive contribution to the Inventions under New Patent Rights contemplated to be owned by BioAtla pursuant to this Section 7.1, or other rights, title or interest within or to such Inventions, Himalaya hereby assigns, and shall cause to be promptly assigned, all of its, its Affiliates’, Licensees’, and Third Party Service Providers’ and their Affiliates’ rights, title and interest in and to such Inventions to BioAtla in the ROW. To the extent BioAtla is deemed to have an inventive contribution to the Inventions under New Patent Rights contemplated to be owned by Himalaya by this Section 7.1, or other rights, title or interest within or to such Inventions, BioAtla hereby assigns, its rights, title and interest in and to such Inventions to Himalaya in the Territory.